Renal Effects and Recovery in Patients Receiving Chimeric Antigen Receptor T Cell Therapy

Chimeric Antigen Receptor T cell (CAR T) therapy has shown significant therapeutic potential but carries risk of treatment related toxicity. There is limited data describing risk of acute kidney injury (AKI) related to CAR T therapy.

Source: Biology of Blood and Marrow Transplantation - January 24, 2020 Category: Hematology Authors: Victoria Gutgarts, Tania Jain, Junting Zheng, Molly A. Maloy, Josel D. Ruiz, Martina Pennisi, Edgar A. Jaimes, Miguel Perales, Insara Jaffer Sathick Tags: 402 Source Type: research